Small RNA Pathways in Mammalian Gametogenesis
2 other identifiers
observational
182
1 country
1
Brief Summary
Basic and clinical research is revealing that various noncoding and small RNAs play important and diverse roles in germ cell development and quality, including X/Y silencing during meiosis, gene regulation, DNA damage responses, and protection of the genome against transposable elements. Indeed, mammalian germ cells are known to harbor multiple small RNA species, including small interfering RNAs (siRNA), microRNAs (miRNA), and germline- specific PIWI- interacting RNAs (piRNA). However, their mechanistic roles in gametogenesis and human infertility are largely uncharacterized. The goal of this study is to elucidate the role of small RNA pathways in the events that give rise to viable euploid gametes. Four projects and three cores are included in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 26, 2016
CompletedFirst Posted
Study publicly available on registry
August 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2024
CompletedJuly 19, 2024
July 1, 2024
10 years
April 26, 2016
July 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Using RNA from men with normal spermatogenesis and men with infertility for multiplexed deep sequencing to identify differentially expressed miRNAs
Detect target mRNAs through correlation analysis of actual mRNA expression profiles obtained from the same patients. At the end of the proposed funding period, project 2 will have identified and confirmed a set of approximately 20-30 miRNA:mRNA interactions in male infertility.
5 years
Eligibility Criteria
Men between the age of 18 and 90 who have testicular cancer and underwent surgery for removal at Weill Cornell Medicine.
You may qualify if:
- Men between the ages of 18-90 who have testicular cancer and underwent surgery at Weill Cornell Medicine.
You may not qualify if:
- Women, men outside of the age parameters
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medicine
New York, New York, 10065, United States
Biospecimen
Testicular tissue, penile tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter N Schlegel, M.D.
Weill Medical College of Cornell University
- PRINCIPAL INVESTIGATOR
Paula E. Cohen, Ph.D.
Cornell University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2016
First Posted
August 12, 2016
Study Start
April 1, 2014
Primary Completion
March 20, 2024
Study Completion
March 20, 2024
Last Updated
July 19, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share